Patent ID: 8084498
Filing Date: 2011-12-27
Classification: A61P,C07C,C07D,C07F

Abstract:
1. A method for treating diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, or insulin resistance, relating to diabetes, comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound selected from a group consisting of: t-butyl-1-[9-[1-(tert-butyoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; 11-(1-carboxycyclopropyl)-2,2-dimethyl-7-oxoundecanoic acid; 1-[9-(1-carboxycyclopropyl)-5-oxononyl]-1-cyclopropanecarboxylic acid; 11-(1-carboxycyclobutyl)-2,2-dimethyl-7-oxoundecanoic acid; 1-[9-(1-carboxycyclobutyl)-5-oxononyl]-1-cyclobutanecarboxylic acid; 1-[9-(1-carboxycyclopentyl)-5-oxononyl]-1-cyclopentylcarboxylic acid; 13-(1-carboxycyclopropyl)-2,2-dimethyl-8-oxotridecanoic acid; 1-[11-(1-carboxycyclopropyl)-6-oxoundecyl]-1-cyclopropanecarboxylic acid; and 1-[11-(1-carboxycyclopentyl)-6-oxoundecyl]-1-cyclopentanecarboxylic acid; or a pharmaceutically acceptable salt thereof.